As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates a regenerating liver, offering new hope for future treatments. The ...

The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...

The market is experiencing a significant transition from traditional 2D cell cultures to more sophisticated 3D liver models and liver-on-chip microfluidic systems. These new-generation systems better ...

Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup. More than 100 million people in the United States suffer from metabolic ...